A systematic review of phase II trials exploring anti-PD-1/PD-L1 combinations in patients with solid tumors
Federica Martorana, Ilaria Colombo, Giorgio Treglia, Silke Gillessen, Anastasios Stathis
Topics & Concepts
MedicineDurvalumabAtezolizumabPembrolizumabNivolumabInternal medicineAdverse effectClinical endpointClinical trialOncologyAvelumabPhases of clinical researchPlaceboRadiation therapyCancerImmunotherapyAlternative medicinePathologyCancer Immunotherapy and BiomarkersCAR-T cell therapy researchStatistical Methods in Clinical Trials